Isoagglutinin adsorption in ABO-incompatible transplantation

Transfusion and Apheresis Science

Volumn 43, Issue 2, 2010, Pages 231-235

  Genberg, Helena ^a,b   Kumlien, Gunilla ^b   Wennberg, Lars ^a,b   Tydén, Gunnar ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

ABO incompatible; Antigen specific immunoadsorption; Kidney transplantation; Rituximab; Therapeutic apheresis

Indexed keywords

CORTICOSTEROID; CREATININE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ADULT; ANTIGEN SPECIFICITY; APHERESIS; ARTICLE; B LYMPHOCYTE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FILTRATION; GRAFT SURVIVAL; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFECTIOUS COMPLICATION; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION; MEDICAL INSTRUMENTATION; ORGAN TRANSPLANTATION; PLASMAPHERESIS; SINGLE DRUG DOSE; SPLENECTOMY; SURGICAL RISK;

ABO BLOOD-GROUP SYSTEM; ADSORPTION; AGGLUTININS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; B-LYMPHOCYTES; BLOOD COMPONENT REMOVAL; BLOOD GROUP INCOMPATIBILITY; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; STEROIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77958153286     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2010.07.016     Document Type: Article

References (35)

1. Cecka J.M. The UNOS renal transplant registry. Clin Transplants 2001, 1-18.
2. Cecka J.M. The OPTN/UNOS renal transplant registry. Clin Transplants 2005, 1-16.
3. Davis C.L., Delmonico F.L. Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol 2005, 16(7):2098-2110.
4. Liefeldt L., Giessing M., Budde K., Neumayer H.H. Contraindications to living donor kidney transplantation. Deutsche medizinische Wochenschrift (1946) 2005, 130(36):2039-2042.
5. Rydberg L., Breimer M.E., Samuelsson B.E., Brynger H. Blood group ABO-incompatible (A2 to O) kidney transplantation in human subjects: a clinical, serologic, and biochemical approach. Transplant Proc 1987, 19(6):4528-4537.
6. Nelson P.W., Landreneau M.D., Luger A.M., Pierce G.E., Ross G., Shield C.F., et al. Ten-year experience in transplantation of A2 kidneys into B and O recipients. Transplantation 1998, 65(2):256-260.
7. Alexandre G.P., De Bruyere M., Squifflet J.P., Moriau M., Latinne D., Pirson Y. Human ABO-incompatible living donor renal homografts. Netherlands J Med 1985, 28(6):231-234.
8. Alexandre G.P., Squifflet J.P., De Bruyere M., Latinne D., Reding R., Gianello P., et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987, 19(6):4538-4542.
9. Cook D.J., Graver B., Terasaki P.I. ABO incompatibility in cadaver donor kidney allografts. Transplant Proc 1987, 19(6):4549-4552.
10. Takahashi K., Saito K. Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplantation 2006, 13(2):118-122.
11. Tanabe K., Takahashi K., Sonda K., Onituka S., Yamaguchi Y., Agishi T., et al. Clinicopathological analysis of rejection episodes in ABO-incompatible kidney transplantation. Transplant Proc 1996, 28(3):1447-1448.
12. Gloor J.M., Lager D.J., Moore S.B., Pineda A.A., Fidler M.E., Larson T.S., et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003, 75(7):971-977.
13. Montgomery R.A. ABO incompatible transplantation: to B or not to B. Am J Transplant 2004, 4(7):1011-1012.
14. Tyden G., Kumlien G., Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003, 76(4):730-731.
15. Bosch T. Therapeutic apheresis-state of the art in the year 2005. Ther Apher Dial 2005, 9(6):459-468.
16. Belak M., Borberg H., Jimenez C., Oette K. Technical and clinical experience with protein A immunoadsorption columns. Transfusion Sci 1994, 15(4):419-422.
17. Belak M., Widder R.A., Brunner R., Borberg H., Haupt W.F. Immunoadsorption with protein A sepharose or silica. Lancet 1994, 343(8900):792-793.
18. Pierson R.N., Loyd J.E., Goodwin A., Majors D., Dummer J.S., Mohacsi P., et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy. Transplantation 2002, 74(1):79-84.
19. Tanabe K. Double-filtration plasmapheresis. Transplantation 2007, 84(12 Suppl.):S30-32.
20. Agishi T., Kaneko I., Hasuo Y., Hayasaka Y., Sanaka T., Ota K., et al. Double filtration plasmapheresis. Trans - Am Soc Artif Internal Organs 1980, 26:406-411.
21. Takahashi K. Accommodation in AB0-incompatible Kidney Transplantation 2004, Elsevier, Amsterdam.
22. Kumlien G., Ullstrom L., Losvall A., Persson L.G., Tyden G. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006, 46(9):1568-1575.
23. Squifflet J.P., De Meyer M., Malaise J., Latinne D., Pirson Y., Alexandre G.P. Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later. Exp Clin Transplant 2004, 2(1):208-213.
24. Segev D.L., Simpkins C.E., Warren D.S., King K.E., Shirey R.S., Maley W.R., et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005, 5(10):2570-2575.
25. Genberg H., Kumlien G., Wennberg L., Berg U., Tyden G. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 2008, 85(12):1745-1754.
26. Tyden G., Kumlien G., Genberg H., Sandberg J., Lundgren T., Fehrman I. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005, 5(1):145-148.
27. Tyden G., Donauer J., Wadstrom J., Kumlien G., Wilpert J., Nilsson T., et al. Implementation of a Protocol for ABO-incompatible kidney transplantation - a three-center experience with 60 consecutive transplantations. Transplantation 2007, 83(9):1153-1155.
28. Genberg H., Kumlien G., Wennberg L., Tyden G. Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab. Transplantation 2007, 84(12 Suppl.):S44-47.
29. Mourant A.E., Kopeć A.C., Domaniewska-Sobczak K. The distribution of the human blood groups and other polymorphisms 1976, Oxford University Press.
30. Chirnside A., Urbaniak S.J., Prowse C.V., Keller A.J. Coagulation abnormalities following intensive plasma exchange on the cell separator. II. Effects on factors I, II, V, VII, VIII, IX, X and antithrombin III. Brit J Haematol 1981, 48(4):627-634.
31. Domen R.E., Kennedy M.S., Jones L.L., Senhauser D.A. Hemostatic imbalances produced by plasma exchange. Transfusion 1984, 24(4):336-339.
32. McLeod B.C., Sniecinski I., Ciavarella D., Owen H., Price T.H., Randels M.J., et al. Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion 1999, 39(3):282-288.
33. Tanabe K., Ishida H., Shimizu T., Omoto K., Shirakawa H., Tokumoto T. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Contrib Nephrol 2009, 162:61-74.
34. Gloor J.M., Cosio F.G., Rea D.J., Wadei H.M., Winters J.L., Moore S.B., et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006, 6(8):1841-1847.
35. Montgomery R.A., Locke J.E., King K.E., Segev D.L., Warren D.S., Kraus E.S., et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 2009, 87(8):1246-1255.